Systems Bases Pharmacology for Psychiatry Flashcards
SSRI examples
Fluoxetine
Paroxetine
Sertraline
Citalopram
Escitalopram
Indications for SSRIs
Depression
Anxiety disorders
Panic disorders
OCD
PTSD
Similarities between SSRIs
Indications
Mechanism of action
Delayed onset of action (10-14 days)
Efficacy
Relative safety in overdose
Advisability of prolonged course
Interactions
Differences between SSRIs
Half life: paroxetine shortest (20 hours), fluoxetine longest (2-4 days)
Propensity to cause discontinuation syndrome f stopped abruptly
Side effect profiles: fluoxetine causes agitation most commonly
Individual differences: people are different
SSRI discontinuation syndrome
Occurs in cessation of SSRI especially when abrupt
Symptoms
- agitation and anxiety
- dizziness, balance problems
- nausea, diarrhoea
- flu like symptoms
Commonest with paroxetine
Treatment for SSRI discontinuation syndrome
Reassurance and monitoring
Reintroduction of drug with tapered withdrawal
Consider alternative antidepressant of anxiolytic
Tricyclic antidepressants
Indications similar to SSRIs although not as widely used outside of depression
Efficacy in major depression similar to SSRIs
Rarely used first line nowadays due to adverse effects and overdose risk
Examples of tricyclic antidepressants
Amitriptyline
Imipramine
Lofepramine
Dotheipin
Mechanism of tricyclic antidepressants
Bind to NA and 5HT reuptake inhibitors, increasing monoamine levels in synaptic cleft
Also have pronounced anticholinergic (antimuscarinic) effects
TCA properties are variable
Adverse effects of tricyclic antidepressants
Anticholinergic effects
- dry mouth
- constipation
- urinary retention
- cognitive effects
Other adverse effects
- psychotropic effects (agitation, nightmares)
- sexual dysfunction
- akathisia
- muscle twitches
- cardiac arrhythmias
Overdose of tricyclic antidepressants
Neurological and cardiovascular effects
- confusion
- tachycardia/ other arrhythmias
- hypotension
- mydriasis
Seizure
Coma
Cardiorespiratory arrest
Other antidepressants
Venlafaxine: SNRI
- more pronounced dose-response effect than other antidepressants
- particularly effective for mixed anxiety and depression
- side effects: headache, nausea, hypertension, discontinuation syndrome
Duloxetine: SNRI
- without concerns such as hypertension
Moclobemide: monoamine oxidase inhibitor
- usually reserved for treatment resistant depression or atypical depression
Reboxetine: highly selective NA reuptake inhibitor
- recent controversy over pharma data
Monoamine oxidase inhibitors
Selegiline: used in Parkinson’s
Prevents action of monoamine oxidase
Prevents 5HT, DA and NA being broken down
MOAI interactions
Foods
- most cheeses, red wine, yeast production, liver, broad bean pons, fermented sausage
Tyramine
Hypersensitive effect
Drugs
- serotonin syndrome (don’t combine with SSRIs)
- adrenaline and noradrenaline
- L-dopa
Mirtazapine
Noradrenergic and specific seratonergic antidepressant
Acts at alpha 2 receptors (antagonist)
‘Cuts the break cable’ on serotonin and noradrenaline release
Doesn’t effect sexual dysfunction
Licensed use of antipsychotics
Psychotic illnesses
Bipolar affective disorder
Adjunctive therapy for depressive episodes